Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083)
Clinical trial NCT02601573 · COMPLETED
Trial details
- NCT number
- NCT02601573
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-05
- Primary completion
- 2016-10-18
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.